Table 3 Adjusted odds ratios (95% confidence intervals)  of colon and rectal cancer by quartile levels of plasma saturated and monounsaturated fatty acids (MUFA) and their desaturase indices, the Singapore Chinse Health Studya 

From: Plasma fatty acids and risk of colon and rectal cancers in the Singapore Chinese Health Study

 

1st (low)

2nd

3rd

4th (high)

P trend

Colon cancer

Saturated fatty acids

     

 Palmitic acid (16:0)

1.00 (Referent)

0.77 (0.40–1.49)

0.71 (0.37–1.36)

0.41 (0.20–0.83)

0.016

 Stearic acid (18:0)

1.00 (Referent)

0.97 (0.55–1.69)

0.96 (0.56–1.64)

0.55 (0.30–0.99)

0.070

MUFAs

     

 Palmitoleic acid (16:1)

1.00 (Referent)

0.79 (0.44–1.42)

0.81 (0.46–1.41)

0.51 (0.28–0.95)

0.051

 Oleic acid (18:1)

1.00 (Referent)

0.56 (0.30–1.04)

0.69 (0.37–1.28)

0.39 (0.20–0.76)

0.015

Stearoyl-coenzyme A desaturase (SCD)-1 indices

     

 Palmitoleic:Palmitic acid ratio

1.00 (Referent)

0.79 (0.43–1.44)

0.93 (0.54–1.59)

0.58 (0.31–1.08)

0.165

 Oleic:Stearic acid ratio

1.00 (Referent)

0.79 (0.41–1.51)

0.58 (0.28–1.23)

0.42 (0.19–0.92)

0.024

Rectal cancer

     

Saturated fatty acids

     

 Palmitic acid (16:0)

1.00 (Referent)

0.92 (0.46–1.83)

1.15 (0.55–2.44)

1.50 (0.65–3.44)

0.312

 Stearic acid (18:0)

1.00 (Referent)

1.55 (0.78–3.09)

0.84 (0.39–1.82)

1.72 (0.79–3.75)

0.356

MUFAs

     

 Palmitoleic acid (16:1)

1.00 (Referent)

0.81 (0.40–1.62)

0.98 (0.50–1.90)

1.10 (0.51–2.39)

0.768

 Oleic acid (18:1)

1.00 (Referent)

1.70 (0.86–3.36)

1.43 (0.68–3.01)

1.77 (0.80–3.91)

0.219

SCD-1 indices

     

 Palmitoleic:Palmitic acid ratio

1.00 (Referent)

0.90 (0.45–1.80)

1.12 (0.49–2.58)

1.09 (0.50–2.36)

0.743

 Oleic:Stearic acid ratio

1.00 (Referent)

1.54 (0.76–3.12)

1.26 (0.62–2.58)

1.15 (0.48–2.76)

0.730

  1. a Odds ratios are adjusted for body mass index (<20, 20–24, 24–28, ≥28 kg/m2), smoking (never, light, heavy), education level (none, primary, ≥secondary), alcohol use (none, <7, ≥7 drinks/week), weekly physical activity (yes, no), history of diabetes (yes, no), and use of nonsteroidal anti-inflammatory drugs (NSAIDs) (yes, no)